Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Direct DNA damage via beta radiation refers to the physical and chemical injuries sustained by cell DNA when exposed to beta particles. While the major component of beta radiation damage is indirect (mediated through ROS that create SSBs, DSBs, and base modifications), some direct DNA damage does occur when beta particles physically collide with DNA, ionizing atoms, breaking chemical bonds, and causing strand breaks. This damage triggers cellular DNA repair pathways (notably base excision repair and non-homologous end joining) or leads to cell cycle arrest, apoptosis, or permanent genomic instability. These molecular events underlie both the desired therapeutic effects (e.g., in cancer radiopharmaceuticals) and the key toxicities of beta-emitting agents, including the potential for secondary malignancies and normal tissue injury.
Induction of DNA damage directly via ionization (breaking DNA strands or bases by direct collision/energy transfer); Generation of reactive oxygen species (ROS), causing indirect DNA damage; Induction of single-strand breaks (SSBs) and double-strand breaks (DSBs); Initiation of apoptosis via DNA damage response pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Direct DNA damage via beta radiation.